Sanofi

Sanofi, a global Pharmaceutical Preparation Manufacturing company headquartered in France, is actively engaged in reducing its greenhouse gas (GHG) emissions and has set ambitious climate commitments.

Recent Emissions Data:

• 2025: Sanofi reported total GHG emissions of approximately 4.45 billion kg CO2e. This comprised about 235 million kg CO2e from Scope 1 emissions and approximately 70 million kg CO2e from Scope 2 emissions (market-based). Scope 3 emissions were significantly higher, at approximately 3.44 billion kg CO2e, with purchased goods and services accounting for the largest portion (around 2.39 billion kg CO2e).
• 2024: Total emissions were approximately 4.66 billion kg CO2e, with Scope 1 at about 299 million kg CO2e and Scope 2 (market-based) at approximately 76 million kg CO2e. Scope 3 emissions totalled around 3.50 billion kg CO2e.
• 2023: Total emissions were approximately 4.80 billion kg CO2e, with Scope 1 at about 288 million kg CO2e and Scope 2 (market-based) at approximately 83 million kg CO2e. Scope 3 emissions were around 3.79 billion kg CO2e.
• 2022: Total emissions stood at approximately 4.74 billion kg CO2e, including Scope 1 emissions of about 362 million kg CO2e and Scope 2 (market-based) emissions of roughly 140 million kg CO2e. Scope 3 emissions amounted to approximately 4.24 billion kg CO2e.

Climate Commitments and Reduction Targets:

Sanofi has established a comprehensive set of climate targets aligned with the Science Based Targets initiative (SBTi) to limit global warming to 1.5°C. Key commitments include:

• Near-Term Targets (by 2030):

  • Reduce absolute Scope 1 and 2 GHG emissions by 55% from a 2019 baseline.
  • Reduce absolute Scope 3 GHG emissions from purchased goods and services, capital goods, fuel and energy-related activities, upstream transportation and distribution, waste generated in operations, business travel, and employee commuting by 30% from a 2019 baseline.
  • Increase annual sourcing of renewable electricity to 100% by 2030.

• Long-Term Targets:

  • Achieve net-zero GHG emissions across the entire value chain by 2045.
  • A trajectory towards carbon neutrality by 2030.
  • Commitment to reduce absolute Scope 1, 2, and 3 GHG emissions by 90% by FY2045 from a FY2019 base year.

Sanofi's approach involves a strong focus on reducing emissions from its operations (Scope 1 and 2) and extensively addressing its value chain emissions (Scope 3), particularly in categories like purchased goods and services, which represent a significant portion of its overall footprint. The company is on track to meet its short-term renewable electricity goals.